查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046381

全球美容醫學市場－產業規模、佔有率、趨勢、機會和預測：按手術類型、地區和競爭格局分類，2021-2031年

Aesthetic Medicine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Procedure Type (Invasive procedures, Non-invasive procedure ), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球美容醫學市場預計將從 2025 年的 1,340.2 億美元大幅成長至 2031 年的 2,772.5 億美元，複合年成長率為 12.88%。

該市場涵蓋一系列旨在改善外觀和解決瑕疵的外科和非手術療法。推動該市場蓬勃發展的主要因素包括：全球人口老化帶來的容顏煥發、可支配收入增加使得更多人能夠獲得特定療法，以及社會對美容醫學的接受度不斷提高。這些因素共同作用，使美容手術從少數富人的奢侈品轉變為大眾普遍的整裝儀容護理。根據國際美容整形外科學會（ISAPS）2024年發布的報告，全球整形外科醫師已實施超過1,740萬例外科手術和超過2,050萬例非手術療法。

市場概覽
預測期 2027-2031
市場規模：2025年 1340.2億美元
市場規模：2031年 2772.5億美元
複合年成長率：2026-2031年 12.88%
成長最快的細分市場 肉毒桿菌注射
最大的市場 北美洲

市場促進因素

市場擴張的主要驅動力是消費者對非侵入性和微創美容手術日益成長的需求，他們越來越傾向於追求更自然的效果和更短的恢復期。這種轉變促使業界重心從外科手術轉向肉毒桿菌和玻尿酸注射等「微調」療法。年輕一代對預防性抗衰老措施的興趣日益濃厚，這一趨勢尤其明顯，迫使診所重新評估其服務項目。根據美國臉部整形與重組外科學會 (AAFPRS) 於 2025 年 2 月發布的《2024 年年度趨勢調查》，微創手術在 2024 年佔臉部整形外科醫生所有手術的 80%，凸顯了非手術方案日益成長的受歡迎程度。同時，能量型設備和注射技術的不斷進步，透過提高治療效果和病人安全性，提升了市場價值。生物促效劑和新一代調變器的創新正在拓展可治療疾病的範圍，使醫療專業人員能夠提供更自然、更持久的治療效果。這些突破性進展不僅留住了現有患者，也吸引了尋求可靠美容解決方案的新興消費族群。根據高德美公司發布的「2024 全年業績報告」（2025 年 2 月），該公司注射美容業務的淨銷售額為 22.99 億美元，年成長 9.6%（不計外匯波動的影響）。同時，Evorus 2024 全年淨銷售額達到創紀錄的 2.663 億美元，年增 32%，進一步推動了該領域的蓬勃發展。

市場挑戰

全球美容醫學市場快速擴張的一大挑戰是醫療設備和手術領域嚴格的法規環境。皮膚填充劑、植入和雷射系統等美容產品的製造商必須應對美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等衛生監管機構制定的複雜核准流程。這些機構將美容領域的創新技術歸類為關鍵醫療設備，並要求進行廣泛且昂貴的臨床試驗以證明其安全性和有效性。這種嚴格的監管顯著增加了產品開發所需的資金，並延緩了先進技術的市場推廣。因此，高昂的合規成本成為小規模創新者和新創企業的障礙，阻礙了競爭，並延緩了新治療方法的上市。這種監管瓶頸限制了產品多樣化，並阻礙了企業靈活應對不斷變化的患者需求。鑑於需要監管的治療項目數量龐大，嚴格的監管至關重要。美國整形外科醫師協會（ASPS）的數據顯示，2024年將進行超過2850萬例微創美容治療方法。然而，雖然這種毫不妥協的標準對於公共安全至關重要，但它不可避免地會減緩市場的整體成長和適應能力。

市場趨勢

一個關鍵的市場趨勢是減重後臉部年輕化解決方案的興起，這主要得益於GLP-1受體促效劑的廣泛應用。這些藥物帶來的快速減重往往會導致臉部容量顯著減少和皮膚鬆弛（俗稱「奧澤姆皮臉」），需要進行除傳統抗衰老療法之外的矯正治療。診所發現，越來越多的患者需要進行結構性修復以解決這些形態變化，而不僅僅是表面改善。根據美國臉部整形與重組外科醫師協會於2025年2月發布的《2024年度趨勢調查》，臉部整形外科醫師進行的脂肪移植手術在過去一年中增加了50%，這一激增歸因於患者希望彌補藥物引起的減重造成的容量損失。同時，人工智慧（AI）和擴增實境（AR）在個人化診斷中的應用正在改變患者參與度。醫療機構正在應用複雜的演算法來即時分析皮膚狀況，從而實現數據驅動的提案，並增強消費者的信心。這項技術超越了簡單的虛擬試妝，提供深入的臨床洞察，有效彌合了居家護理與專業美容服務之間的差距。歐萊雅2024年度報告（2025年2月發布）重點強調了這一趨勢，指出其美容科技服務已在全球66個國家/地區被使用超過1.1億次，證實了美容護理領域對人工智慧診斷工具的強勁需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球醫美市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 治療類型（侵入性手術{隆乳、抽脂、隆鼻、眼瞼手術、腹部手術等}）、非侵入性手術{肉毒桿菌注射、軟組織填充、化學換膚、雷射除毛、微晶換膚等}
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美美容醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲醫美市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區醫美市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲美容醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲美容醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球醫美市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Evolus, Inc.
  • Cynosure LLC.
  • Revance Therapeutics, Inc.
  • Galderma SA
  • Alma Lasers Inc.
  • AbbVie Inc.
  • Solta Medical Inc.
  • Lumenis Inc.
  • Syneron Inc.
  • Bausch Health Companies, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16109

The Global Aesthetic Medicine Market is projected to expand significantly, from USD 134.02 billion in 2025 to USD 277.25 billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 12.88%. This market covers a wide array of surgical and nonsurgical procedures aimed at improving physical appearance and addressing imperfections. Its widespread growth is primarily driven by an aging global population seeking rejuvenation, increased disposable incomes making elective treatments more accessible, and the rising social acceptance of cosmetic interventions. These combined elements have transformed aesthetic enhancements from exclusive luxuries into standard grooming practices for a diverse population. In 2024, the International Society of Aesthetic Plastic Surgery reported that plastic surgeons globally performed over 17.4 million surgical and 20.5 million nonsurgical procedures.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 134.02 Billion
Market Size 2031USD 277.25 Billion
CAGR 2026-203112.88%
Fastest Growing SegmentBotox Injections
Largest MarketNorth America

Market Driver

The primary driver of market expansion is the escalating demand for non-invasive and minimally invasive aesthetic procedures, with consumers increasingly preferring treatments that offer subtle enhancements and shorter recovery periods. This shift has moved the industry's focus from surgical interventions to 'tweakments' like neurotoxins and dermal fillers, a trend notably reflected in younger demographics' growing preference for preventative anti-aging measures, compelling clinics to adjust their service portfolios. The American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Trends Survey' from February 2025 indicated that minimally invasive procedures accounted for 80% of all procedures performed by facial plastic surgeons in 2024, highlighting the prevalence of nonsurgical options. Concurrently, ongoing technological advancements in energy-based devices and injectables are boosting market value by improving treatment efficacy and patient safety. Innovations in biostimulators and next-generation neuromodulators are broadening the scope of treatable conditions, enabling practitioners to deliver more natural and longer-lasting results. These breakthroughs not only retain existing patients but also attract new consumer segments seeking reliable aesthetic solutions. Galderma's 'Full Year 2024 Financial Results' (February 2025) reported net sales of $2.299 billion for its Injectable Aesthetics unit, a 9.6% year-on-year increase at constant currency, while Evolus achieved a record total net revenue of $266.3 million in full year 2024, marking 32% growth, further demonstrating the sector's dynamism.

Market Challenge

A significant challenge hindering the rapid expansion of the Global Aesthetic Medicine Market is the stringent regulatory environment for medical devices and procedures. Manufacturers of aesthetic products, including dermal fillers, implants, and laser systems, must navigate intricate approval processes imposed by health authorities like the FDA and EMA. These bodies categorize aesthetic innovations with critical medical devices, demanding extensive and expensive clinical trials to prove safety and efficacy. Such rigorous oversight substantially increases the capital needed for product development and postpones the market entry of advanced technologies. As a result, the high cost of compliance acts as a barrier for smaller innovators and startups, stifling competition and slowing the introduction of new treatments to consumers. This regulatory bottleneck restricts product diversification and impedes the market's agility in addressing evolving patient needs. While the vast number of treatments requiring oversight, such as the over 28.5 million minimally invasive cosmetic procedures performed in 2024 according to the American Society of Plastic Surgeons, necessitates strict vigilance, these uncompromising standards, though essential for public safety, inevitably decelerate the market's overall growth and adaptability.

Market Trends

A significant market trend is the rise of post-weight loss facial rejuvenation solutions, largely spurred by the extensive use of GLP-1 receptor agonists. The rapid weight reduction these medications induce often results in considerable facial volume loss and skin laxity, colloquially known as "Ozempic Face," which demands corrective procedures beyond typical anti-aging treatments. Clinics are increasingly seeing patients who need structural restoration to address these morphological changes, rather than just surface-level enhancements. The American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Trends Survey' from February 2025 reported a 50 percent increase in fat grafting procedures performed by facial plastic surgeons in the past year, attributing this surge to patients correcting volume deficits from medication-induced weight loss. Simultaneously, the incorporation of artificial intelligence and augmented reality for personalized diagnostics is transforming patient interaction. Providers are implementing advanced algorithms that analyze skin conditions in real-time, enabling data-driven recommendations that boost consumer confidence. This technology extends beyond simple virtual try-ons to provide profound clinical insights, effectively connecting at-home care with professional aesthetic services. L'Oreal's '2024 Annual Report' (February 2025) highlighted this trend, noting over 110 million uses of its Beauty Tech services across 66 countries, confirming robust demand for AI-powered diagnostic tools in aesthetic care.

Key Market Players

  • Evolus, Inc.
  • Cynosure LLC.
  • Revance Therapeutics, Inc.
  • Galderma S.A.
  • Alma Lasers Inc.
  • AbbVie Inc.
  • Solta Medical Inc.
  • Lumenis Inc.
  • Syneron Inc.
  • Bausch Health Companies, Inc.

Report Scope

In this report, the Global Aesthetic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aesthetic Medicine Market, By Procedure Type

  • Invasive procedures
  • Non-invasive procedure

Aesthetic Medicine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aesthetic Medicine Market.

Available Customizations:

Global Aesthetic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aesthetic Medicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Procedure Type (Invasive procedures {Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others }), Non-invasive procedure { Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Others }
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America Aesthetic Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Procedure Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Aesthetic Medicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Procedure Type
    • 6.3.2. Canada Aesthetic Medicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Procedure Type
    • 6.3.3. Mexico Aesthetic Medicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Procedure Type

7. Europe Aesthetic Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Procedure Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Aesthetic Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Procedure Type
    • 7.3.2. France Aesthetic Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Procedure Type
    • 7.3.3. United Kingdom Aesthetic Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Procedure Type
    • 7.3.4. Italy Aesthetic Medicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Procedure Type
    • 7.3.5. Spain Aesthetic Medicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Procedure Type

8. Asia Pacific Aesthetic Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Procedure Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Aesthetic Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Procedure Type
    • 8.3.2. India Aesthetic Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Procedure Type
    • 8.3.3. Japan Aesthetic Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Procedure Type
    • 8.3.4. South Korea Aesthetic Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Procedure Type
    • 8.3.5. Australia Aesthetic Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Procedure Type

9. Middle East & Africa Aesthetic Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Procedure Type
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Aesthetic Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Procedure Type
    • 9.3.2. UAE Aesthetic Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Procedure Type
    • 9.3.3. South Africa Aesthetic Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Procedure Type

10. South America Aesthetic Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Procedure Type
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Aesthetic Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Procedure Type
    • 10.3.2. Colombia Aesthetic Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Procedure Type
    • 10.3.3. Argentina Aesthetic Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Procedure Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Aesthetic Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Evolus, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cynosure LLC.
  • 15.3. Revance Therapeutics, Inc.
  • 15.4. Galderma S.A.
  • 15.5. Alma Lasers Inc.
  • 15.6. AbbVie Inc.
  • 15.7. Solta Medical Inc.
  • 15.8. Lumenis Inc.
  • 15.9. Syneron Inc.
  • 15.10. Bausch Health Companies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer